2m 2m 2m 2m 2m 2m 2m
MONOPAR THERAPE (MNPR)
NASDAQ
$110.00-$0.26 (-0.24%)
Price as of Sep 11, 2026 7:59 PM EDT- $740.1MMarket Cap
- 124.01%1-Year Change
- BiotechnologyIndustry
MONOPAR THERAPE (MNPR)
$110.00-$0.26 (-0.24%)
MNPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $110.26 | ||
Change | +$0.30 (+0.27%) | ||
Open | $113.84 | ||
High | $113.84 | ||
Low | $109.77 | ||
Previous Close | $109.96 | ||
Volume | 90,261 | ||
30-Day Average Volume | 171,248 | ||
1-Week Change | -6.21% | ||
1-Month Change | -3.67% | ||
1-Year Change | 124.01% | ||
3-Year Change | 3,668.93% | ||
5-Year Change | 296.62% | ||
Fundamentals | |||
Shares Outstanding | 6.7M | ||
Total Assets | $135.0M | ||
Market Cap | $740.1M | ||
Enterprise Value | $687.3M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$5.3M | ||
Free Cash Flow | -$3.2M | ||
EBIT | -$5.3M | ||
EBITDA | -$5.3M | ||
Net Working Capital | $130.7M | ||
EPS | -$0.62 | ||
Enterprise Value/EBITDA | -129 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -178 | ||
PEG | 5 | ||
Price/Free Cash Flow | -228 | ||
Price/Operating Cash Flow | -228 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 08/13/2024 | ||
Earnings & Revenue